FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETs by Lara Toffoli, Angeliki Ditsiou, Luca Triboli, Victorine Hamm, Eva Moschioni, Francesca D’Este, Teresa Gagliano

Subjects: Get full text

Research Progress of PROTAC-Degraded CDKs in the Treatment of Breast Cancer by Zhao K, Zhang J, Yang Z, Wang R, Shi Y, Ji Y, Zhang S, Liu M

Subjects: Get full text

Recent Advances in CBP/EP300 Degraders by Leonardo Palaferri, Iván Cheng-Sánchez, Cristina Nevado

Subjects: Get full text

Potential application of proteolysis targeting chimera (PROTAC) modification technology in natural products for their targeted protein degradation by Guliang Yang, Haiyan Zhong, Xinxin Xia, Zhiwen Qi, Chengzhang Wang, Shiming Li

Subjects: “…PROTAC…”
Get full text

The Peptide PROTAC Modality: A New Strategy for Drug Discovery by Youmin Zhu, Yu Dai, Yuncai Tian

Subjects: “…peptide PROTAC…”
Get full text

Modeling PROTAC degradation activity with machine learning by Stefano Ribes, Eva Nittinger, Christian Tyrchan, Rocío Mercado

Subjects: “…PROTAC…”
Get full text

Palbociclib as an Antitumor Drug: A License to Kill by Agnieszka Łupicka-Słowik, Federica Cossu, Marcin Sieńczyk

Subjects: Get full text

Identification and removal of a cryptic impurity in pomalidomide-PEG based PROTAC by Bingnan Wang, Yong Lu, Chuo Chen

Subjects: Get full text

A pH-responsive PROTAC-based nanosystem triggers tumor-specific ferroptosis to construct in situ tumor vaccines by Linghong Huang, Xinyuan Sun, Qinhua Zuo, Ting Song, Ning Liu, Zonghua Liu, Wei Xue

Subjects: Get full text

Corrigendum to “Modeling PROTAC degradation activity with machine learning” [Artif. Intell. Life Sci. 6 (2024) 100104] by Stefano Ribes, Eva Nittinger, Christian Tyrchan, Rocío Mercado

Subjects: “…PROTAC…”
Get full text

Development of MDM2‐Targeting PROTAC for Advancing Bone Regeneration by Sol Jeong, Jae‐Kook Cha, Wasim Ahmed, Jaewan Kim, Minsup Kim, Kyung Tae Hong, Wonji Choi, Sunjoo Choi, Tae Hyeon Yoo, Hyun‑Ju An, Seung Chan An, Jaemin Lee, Jimin Choi, Sun‐Young Kim, Jun‐Seok Lee, Soonchul Lee, Junwon Choi, Jin Man Kim

Subjects: Get full text

Negative Immune Checkpoint Inhibitors by Magda Drewniak-Świtalska, Paulina Fortuna, Małgorzata Krzystek-Korpacka

Subjects: Get full text

Targeting Stat3 with conditional knockout or PROTAC technology alleviates renal injury by Limiting pyroptosisResearch in context by Ming-lu Ji, Jia-nan Wang, Ming-fei Wu, Chuan-hui Xu, Meng-meng Zhang, Wen-bao Chang, Xin-fei Mao, Chao Li, Ju-tao Yu, Dan-feng Zhang, Xiao-guo Suo, Shao-xi Diao, Nan-nan Ma, Ying Chen, Rui Hou, Hao Lu, Shuai-shuai Xie, Yu-hang Dong, Qi Zhu, Xin Chen, Tao Xu, Wei Shao, Juan Jin, Jia-gen Wen, Xiao-wu Dong, Wen-bin Wang, Jin-xin Che, Xiao-ming Meng

Subjects: Get full text

PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation by Endry Wahyu Syahputra, Hyunji Lee, Hyukjun Cho, Hyun Jin Park, Kwang-Su Park, Duhyeong Hwang

Subjects: “…PROTAC…”
Get full text

PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development by Amith Anugu, Pankaj Singh, Dharambir Kashyap, Jillwin Joseph, Sheetal Naik, Subhabrata Sarkar, Kamran Zaman, Manpreet Dhaliwal, Shubham Nagar, Tanishq Gupta, Prasanna Honnavar

Subjects: “…PROTAC…”
Get full text

Role and therapeutic potential of the NEDD4 family in breast cancer by Xiaoxiao Zhang, Sijie Li

Subjects: Get full text

HomoPROTACKeap1: A new strategy of chemical knockdown of Keap1 for allergic rhinitis by Xiaofeng Qi

Subjects: Get full text

Discovery of a potent PROTAC degrader for RNA demethylase FTO as antileukemic therapy by Lu Liu, Yuanlai Qiu, Yuying Suo, Siyao Tong, Yiqing Wang, Xi Zhang, Liang Chen, Yue Huang, Huchen Zhou, Hu Zhou, Ze Dong, Cai-Guang Yang

Subjects: Get full text

Targeted protein degradation by KLHDC2 ligands identified by high-throughput screening by Han Zhou, Tonglian Zhou, Wenli Yu, Liping Liu, Yeonjin Ko, Kristen A Johnson, Ian A Wilson, Peter G Schultz, Michael J Bollong

Subjects: Get full text

Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function by Yuheng Jin, Xuxin Qi, Xiaoli Yu, Xirui Cheng, Boya Chen, Mingfei Wu, Jingyu Zhang, Hao Yin, Yang Lu, Yihui Zhou, Ao Pang, Yushen Lin, Li Jiang, Qiuqiu Shi, Shuangshuang Geng, Yubo Zhou, Xiaojun Yao, Linjie Li, Haiting Duan, Jinxin Che, Ji Cao, Qiaojun He, Xiaowu Dong

Subjects: Get full text